EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022–June 2023

Sara Mazzilli iD, Muhammad K Aslam, Mubashir Ahmed, Yves Wailly, Marta Miazek, Sana Ashraf, Ashok Ravji, William A de Glanville, Petros Isaakidis

Journal of Viral Hepatitis · 2026

DOI: 10.1111/jvh.70103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2026. Verfasst von Sara Mazzilli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Médecins Sans Frontières, Operational Centre Brussels (MSF OCB), Karachi, Pakistan. Hauptthemen laut MEDLINE: Antiviral Agents, Primary Health Care, Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Médecins Sans Frontières.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pakistan has the world's highest hepatitis C virus (HCV) prevalence, yet access to HCV care remains limited. In collaboration with the Ministry of Health Sindh, Médecins Sans Frontières implemented a simplified, decentralised model for HCV screening and treatment at a government‐run primary health centre (PHC) in Baldia Town, Karachi, Pakistan. This cohort study assessed treatment uptake, effectiveness, and retention among patients screened between August 2022 and July 2023. Individuals aged ≥ 12 years were screened using capillary blood rapid diagnostic tests, with HCV viraemia confirmed via GeneXpert. Viraemic patients were treated with 12‐ or 24‐week regimens of sofosbuvir (400 mg) and daclatasvir (60 mg), depending on the fibrosis degree. Cure was defined as a sustained virological response (viral load < 10 IU/mL) at 12 weeks post‐treatment (SVR12). Among 3505 individuals screened, 613 (17.5%) tested HCV‐antibody positive. Of these, 610 received confirmatory viral load testing, revealing 225 (37.9%) HCV RNA positive. A total of 161 (71.6%) initiated treatment, with a median time of 5 days (IQR 2–9) from diagnosis, while 23 (10.2%) were deemed ineligible and 41 (18.2%) lost to follow‐up. Of the 118 patients assessed for SVR12, 114 (96.6%) achieved cure. Overall, 91.3% of those who started treatment completed it. These findings demonstrate the effectiveness of decentralised, primary care–based HCV management in a high‐burden, resource‐limited setting. The model appears feasible in terms of patient‐level outcomes, though broader operational feasibility—including resources and scalability—was not formally assessed. Remaining barriers to treatment initiation and follow‐up need to be addressed to advance national HCV elimination goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsPrimary Health CareHepatitis CHepatitis C, ChronicHumansMalePakistanFemaleMiddle AgedAdultViral LoadSofosbuvirSustained Virologic ResponseHepacivirusCarbamatesPyrrolidinesYoung AdultValineCohort StudiesAdolescentAgedImidazolesDelivery of Health Care, IntegratedMass Screening

Stichwörter der Autor:innen

Pakistandecentralised carehepatitis Cprimary health centre

Substanzen

Antiviral AgentsdaclatasvirSofosbuvirCarbamatesPyrrolidinesValineImidazoles

Autor:innen und Institutionen

  • Médecins Sans Frontières, Operational Centre Brussels (MSF OCB), Karachi, Pakistan.
  • Médecins Sans Frontières, Operational Centre Brussels (MSF OCB), Brussels, Belgium.
  • Rural Health Center, Baldia, Pakistan.
  • Government of Sindh Health Department, Karachi, Pakistan.
  • Department of Hygiene and Epidemiology, Clinical and Molecular Epidemiology Unit, University of Ioannina School of Medicine, Ioannina, Greece.
  • Médecins Sans Frontières, Southern Africa Medical Unit (SAMU), Cape Town, South Africa.

ORCID-Profile: Sara Mazzilli

Förderung

  • Médecins Sans Frontières

Zitieren

APA

Mazzilli, S., Aslam, M. K., Ahmed, M., Wailly, Y., Miazek, M., Ashraf, S., Ravji, A., de Glanville, W. A., & Isaakidis, P. (2026). Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022–June 2023. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70103

Vancouver

Mazzilli S, Aslam MK, Ahmed M, Wailly Y, Miazek M, Ashraf S, et al. Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022–June 2023. Journal of Viral Hepatitis. 2026. doi:10.1111/jvh.70103

BibTeX
@article{Mazzilli2026,
  author = {Mazzilli, Sara and Aslam, Muhammad K and Ahmed, Mubashir and Wailly, Yves and Miazek, Marta and Ashraf, Sana and Ravji, Ashok and de Glanville, William A and Isaakidis, Petros},
  title = {Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022–June 2023},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  doi = {10.1111/jvh.70103}
}
Kostenlos starten →